Bristol-Myers Squibb Company
BMY
$60.66
$0.360.60%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,409.72% | 81.75% | -22.02% | 120.62% | -95.91% |
| Total Depreciation and Amortization | -44.62% | -60.29% | -61.69% | -59.45% | -24.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.14% | -82.76% | 269.98% | -97.05% | 252.58% |
| Change in Net Operating Assets | -229.62% | 78.97% | 100.63% | -1,044.95% | 49.24% |
| Cash from Operations | -55.53% | 12.88% | 68.40% | -31.05% | 4.40% |
| Capital Expenditure | 2.12% | 1.23% | -37.79% | 8.45% | -14.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3,531.91% | -438.51% | 79.24% | 99.61% | 91.91% |
| Divestitures | -16.22% | 9.41% | 0.00% | 0.83% | 38.17% |
| Other Investing Activities | 426.92% | 7.58% | -310.87% | -184.52% | 84.62% |
| Cash from Investing | -643.88% | -677.17% | 64.14% | 97.46% | 85.44% |
| Total Debt Issued | 1,417.04% | -94.74% | -82.21% | -97.69% | -109.59% |
| Total Debt Repaid | -- | 91.66% | 79.43% | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.61% | -3.87% | -3.70% | -3.80% | -5.00% |
| Other Financing Activities | -73.68% | -118.75% | 283.33% | -6.19% | -- |
| Cash from Financing | -267.17% | 61.32% | 54.36% | -106.78% | -269.80% |
| Foreign Exchange rate Adjustments | 103.40% | -105.19% | 681.82% | 246.67% | -288.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.45% | 95.05% | 157.14% | 124.16% | -37.89% |